Methyl 6-O-tosyl-alpha-D-glucopyranoside

Uses

Methyl α-D-Glucopyranoside 6-(4-Methylbenzenesulfonate) is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins.